Knowing what’s growing: Why ductal and intraductal prostate cancer matter-Reference-Cited by-同舟云学术

Knowing what’s growing: Why ductal and intraductal prostate cancer matter

Published:2020-03-04 Issue:533 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Lawrence Mitchell G.¹²³^ORCID,Porter Laura H.¹^ORCID,Clouston David⁴^ORCID,Murphy Declan G.³⁵⁶^ORCID,Frydenberg Mark¹⁷⁸^ORCID,Taylor Renea A.²³⁹^ORCID,Risbridger Gail P.¹²³^ORCID

Affiliation:

1. Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia.

2. Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

3. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.

4. TissuPath, Mount Waverley, VIC 3149, Australia.

5. Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia.

6. Epworth HealthCare, Melbourne, VIC 3000, Australia.

7. Australian Urology Associates, Melbourne, VIC 3000, Australia.

8. Department of Urology, Cabrini Health, Malvern, VIC 3144, Australia.

9. Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.

Abstract

IDC-P and ductal adenocarcinoma are two pathologies that can indicate aggressive primary prostate cancer.

Funder

Victorian Cancer Agency

National Health and Medical Research Council

Faculty of Medicine, Nursing and Health Sciences, Monash University

The Endocrine Society of Australia

EJ Whitten Foundation

Peter and Lyndy White Foundation

TissuPath Pathology

Publisher

American Association for the Advancement of Science (AAAS)